Oncogenic Neu/ErbB-2 Increases Ets, AP-1, and NF-kB-dependent Gene Expression, and Inhibiting Ets Activation Blocks Neu-mediated Cellular Transformation

This publication has 46 references indexed in Scilit:

• Two Distinct Raf Domains Mediate Interaction with Ras
  Journal of Biological Chemistry, 1995
• Heregulin Stimulates Mitogenesis and Phosphatidylinositol 3-Kinase in Mouse Fibroblasts Transfected with erbB2/neu and erbB3
  Journal of Biological Chemistry, 1995
• Aberrant function of the Ras signal transduction pathway in human breast cancer
  Breast Cancer Research and Treatment, 1995
• NIH/3T3 cells transformed with the activated erbB-2 oncogene can be phenotypically reverted by a kinase deficient, dominant negative erbB-2 variant
  Molecular and Cellular Endocrinology, 1994
• Oncogenically activated or ligand-stimulatedneukinase stimulates neurite outgrowth in PC12 cells
  FEBS Letters, 1994
• Signal transduction by the neu/ebrB-2 receptor: A potential target for anti-tumor therapy
  The Journal of Steroid Biochemistry and Molecular Biology, 1992
• Growth factor signaling by receptor tyrosine kinases
  Neuron, 1992
• Transformation suppressor activity of a Jun transcription factor lacking its activation domain
  Nature, 1991
• Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase.
  The Journal of cell biology, 1989
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987